BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 23008714)

  • 1. Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update.
    Bassig BA; Lan Q; Rothman N; Zhang Y; Zheng T
    J Cancer Epidemiol; 2012; 2012():978930. PubMed ID: 23008714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update of the epidemiology of non-Hodgkin's lymphoma.
    Chiu BC; Weisenburger DD
    Clin Lymphoma; 2003 Dec; 4(3):161-8. PubMed ID: 14715098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988.
    Zheng T; Mayne ST; Boyle P; Holford TR; Liu WL; Flannery J
    Cancer; 1992 Aug; 70(4):840-9. PubMed ID: 1643616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increasing incidence and mortality of non-Hodgkin lymphomas. An epidemiological review of recent studies on risk factors for non-Hodgkin lymphoma].
    Zeeb H; Blettner M
    Med Klin (Munich); 2001 Feb; 96(2):87-100. PubMed ID: 11253287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's and non-Hodgkin's lymphomas.
    Hartge P; Devesa SS; Fraumeni JF
    Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
    Howlader N; Shiels MS; Mariotto AB; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic.
    Weisenburger DD
    Ann Oncol; 1994; 5 Suppl 1():19-24. PubMed ID: 8172811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
    Porcu P; Nichols CR
    Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious agents as causes of non-Hodgkin lymphoma.
    Engels EA
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):401-4. PubMed ID: 17337646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.
    Vamvakas EC
    Transfus Med Rev; 2000 Jul; 14(3):258-68. PubMed ID: 10914420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
    Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
    Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of non-Hodgkin lymphoma.
    Grulich AE; Vajdic CM
    Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-Hodgkin lymphomas: a review of the epidemiologic literature.
    Alexander DD; Mink PJ; Adami HO; Chang ET; Cole P; Mandel JS; Trichopoulos D
    Int J Cancer; 2007; 120 Suppl 12():1-39. PubMed ID: 17405121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors.
    Pearce N; Bethwaite P
    Cancer Res; 1992 Oct; 52(19 Suppl):5496s-5500s. PubMed ID: 1394162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.